In this podcast, Frank LoVecchio, MD, discusses typical and atypical presentations of community-acquired bacterial pneumonia (CABP), as well as important considerations for health care providers when determining the site of care for these patients. This podcast is part 1 of a 3-part series on unmet needs in treatment of CABP. For more, visit www.consultant360.com

Episode 8: Moderator Jaspal Singh, MD, MHA, MHS, interviews Aneesa Das, MD, and Seema Khosla, MD, about the main issues affecting sleep medicine today, the evolution of consumer-facing sleep applications and gadgets, and how the COVID-19 pandemic has affected sleep medicine.

In this podcast, William Schaffner, MD, talks about updates from the June 2021 Advisory Committee on Immunization Practices (ACIP), including recommendations for influenza vaccine, pneumococcal vaccines for adults, herpes zoster vaccine, dengue vaccine, and rabies vaccine.

In this podcast, Sarah Bolander, DMSc, PA-C, discusses appropriately identifying and describing common eponymous extremity fractures in a primary care setting. For more, visit www.consultant360.com

In this podcast, Dr Volkmann, director of the UCLA Scleroderma Program and the founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program, discusses treatment and monitoring of patients with systemic sclerosis-related ILD.

In this podcast, William Schaffner, MD, offers tips for clinicians on communicating information to their patients regarding COVID-19 and the COVID-19 vaccines, including dispelling misinformation about the COVID-19 vaccines.

In this podcast, Chuck Vega, MD speaks about the financial implications of various treatments for patients with community-acquired bacterial pneumonia (CABP) and for the care system. He also speaks about the decision of inpatient vs outpatient care. This podcast is part 3 of a 3-part series on managing CABP.

In this podcast, Chuck Vega, MD, speaks about how clinicians determine site and duration of treatment for community-acquired bacterial pneumonia (CABP) based on patients' factors and prior treatment, including the difference in score systems used to predict the severity of CABP and the considerations for inpatient vs outpatient care. This podcast is part 2 of a 3-part series on managing CABP.

In this podcast, Chuck Vega, MD, speaks about how to treat patients with community-acquired bacterial pneumonia (CABP) and how it is managed for the most common presentations, including the typical bacterial pathogens that cause CABP, the most common symptoms, treatment guidelines, and standard workup of CABP.

In this podcast, Forest Arnold, MD, and Michael Egger, MD, speak about their study that aimed to evaluate the cost-effectiveness of adhering to treatment guidelines for community-acquired bacterial pneumonia in elderly patients who are hospitalized, including how the results of their study will impact clinical practice going forward.